Skip to Main Content

NISH (NITAG SUPPORT HUB) 3 - Malaria vaccines: Home

This Library Guide is a collection of useful documents & evidence on the efficacy, effectiveness and impact of the RTS,S/AS01 malaria vaccine to support NITAG members and other policy makers throughout Africa with making evidence-based recommendations.

Library Guide

LibGuides are a content management and information sharing system designed specifically for users of library materials. The platform allows for easy navigation through core and relevant resources in a particular subject field, class, or assignment - in our case:

Useful documents & evidence on the RTS,S/AS01 malaria vaccine

Africa

To include ALL African countries in your search, please copy and paste all the terms below into your search box:

 

Africa OR African OR Algeria OR Angola OR Benin OR Botswana OR "Burkina Faso" OR Burundi OR “Cabo Verde” OR Cameroon OR Cameroun OR "Canary Islands" OR "Cape Verde"  OR "Central African Republic" OR Chad OR Comoros OR Congo OR "Cote d'Ivoire" OR "Democratic Republic of Congo" OR Djibouti OR Egypt OR Eritrea OR eSwatini OR Ethiopia OR Gabon OR Gambia OR Ghana OR Guinea OR Guinea- Bissau OR "Ivory Coast" OR Jamahiriya OR Kenya OR Lesotho OR Liberia OR Libya OR Madagascar OR Malawi OR Mali OR Mauritania OR Mauritius OR Mayotte OR Morocco OR Mozambique OR Namibia OR Niger OR Nigeria OR Principe OR Reunion OR Rwanda OR “Saint Helena” OR “Sao Tome” OR Senegal OR Seychelles OR “Sierra Leone” OR Somalia OR  “St Helena” OR Sudan OR Swaziland OR Tanzania OR Togo OR Tunisia OR Uganda OR “Western Sahara” OR Zaire OR Zambia OR Zimbabwe

WHO articles on Malaria

Malaria

 

Background

Malaria is a serious and sometimes fatal disease caused by a parasite that commonly infects a certain type of mosquito which feeds on humans. People who get malaria are typically very sick with high fevers, shaking chills, and flu-like illness.

Malaria control remains a challenge in many parts of the Sahel and sub-Sahel regions of Africa.

Malaria vaccines